function tests and MRI of the chest can also be done if clinically indicated. On CT, thymoma can look like malignant mesothelioma; however, pleural effusion does not typically occur with thymoma. Alpha-fetoprotein (AFP) and β–human chorionic gonadotropin (β
Search Results
David S. Ettinger, Wallace Akerley, Gerold Bepler, Matthew G. Blum, Andrew Chang, Richard T. Cheney, Lucian R. Chirieac, Thomas A. D'Amico, Todd L. Demmy, Ramaswamy Govindan, Frederic W. Grannis Jr., Thierry Jahan, David H. Johnson, Anne Kessinger, Ritsuko Komaki, Feng-Ming Kong, Mark G. Kris, Lee M. Krug, Quynh-Thu Le, Inga T. Lennes, Renato Martins, Janis O'Malley, Raymond U. Osarogiagbon, Gregory A. Otterson, Jyoti D. Patel, Katherine M. Pisters, Karen Reckamp, Gregory J. Riely, Eric Rohren, Scott J. Swanson, Douglas E. Wood, and Stephen C. Yang
So Kato
enough to impair structural integrity; OVF is caused by universal trabecular thinning that renders a vertebra unable to tolerate the physiologic load. MRI is considered the imaging modality with the strongest discriminant capability, enabling
SSR-PET/MRI.” • “Well-Differentiated Grade 1/2” was added to page headings where applicable. • Testing for inherited genetic syndromes was revised: Genetic counseling and testing for inherited genetic syndromes. Neuroendocrine Tumors, Well
Peter R. Carroll, J. Kellogg Parsons, Gerald Andriole, Robert R. Bahnson, Erik P. Castle, William J. Catalona, Douglas M. Dahl, John W. Davis, Jonathan I. Epstein, Ruth B. Etzioni, Thomas Farrington, George P. Hemstreet III, Mark H. Kawachi, Simon Kim, Paul H. Lange, Kevin R. Loughlin, William Lowrance, Paul Maroni, James Mohler, Todd M. Morgan, Kelvin A. Moses, Robert B. Nadler, Michael Poch, Chuck Scales, Terrence M. Shaneyfelt, Marc C. Smaldone, Geoffrey Sonn, Preston Sprenkle, Andrew J. Vickers, Robert Wake, Dorothy A. Shead, and Deborah A. Freedman-Cass
recommended over any other; a biomarker assay can be performed in addition to multiparametric MRI (mp-MRI)/refined biopsy techniques in the repeat biopsy setting (discussed in the following section); the optimal order of biomarker tests and imaging is unknown
-radiation chemotherapy ( consider collecting stem cells before craniospinal radiation ).” AMED-3 Follow-up: The imaging recommendations changed to “Brain MRI every 3 mos and spine MRI every 6 mos for 2 y; then brain MRI every 6 months and spine MRI every
Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Clair Beard, Sam Bhayani, Graeme B. Bolger, Sam S. Chang, Toni K. Choueiri, Brian A. Costello, Ithaar H. Derweesh, Shilpa Gupta, Steven L. Hancock, Jenny J. Kim, Timothy M. Kuzel, Elaine T. Lam, Clayton Lau, Ellis G. Levine, Daniel W. Lin, M. Dror Michaelson, Thomas Olencki, Roberto Pili, Elizabeth R. Plimack, Edward N. Rampersaud, Bruce G. Redman, Charles J. Ryan, Joel Sheinfeld, Brian Shuch, Kanishka Sircar, Brad Somer, Richard B. Wilder, Mary Dwyer, and Rashmi Kumar
growth rate of the tumor, the panel recommends abdominal imaging (with CT or MRI) within 6 months from initiation of active surveillance, and subsequent imaging (with CT, MRI, or ultrasound) may be performed annually thereafter. All 3 modalities
, HCC-A) HCC-3 • Workup: Multidisciplinary evaluation: ➤ 9th bullet was revised: “Abdominal/pelvic CT or MRI with contrast, if not previously done or needs updating .” ➤ New 10th bullet was added: “Consider referral to a hepatologist
Mary K. Hayes, Mayra Frau, Erica Bloomquist, and Heather Wright
successful LN excision without complication. The mean time interval between WFL and surgery was 162 days (range 4-270, median 191 days). A single supplementary wire was performed for surgeon’s learning curve. No obscuring artifact was noted in 25 MRI exams
Dadasaheb Akolkar, Darshana Patil, Anantbhushan Ranade, Revati Patil, Sachin Apurwa, Sanket Patil, Pradip Fulmali, Pradip Devhare, Navin Srivastava, Ajay Srinivasan, and Rajan Datar
integrated to generate patient-specific therapy recommendations. All patients underwent whole body PET-CT and brain MRI scans prior to start of treatment. Treatment response was determined from follow-up PET-CT scans and used to calculate Objective Response
Therese B. Bevers, Benjamin O. Anderson, Ermelinda Bonaccio, Sandra Buys, Mary B. Daly, Peter J. Dempsey, William B. Farrar, Irving Fleming, Judy E. Garber, Randall E. Harris, Alexandra S. Heerdt, Mark Helvie, John G. Huff, Nazanin Khakpour, Seema A. Khan, Helen Krontiras, Gary Lyman, Elizabeth Rafferty, Sara Shaw, Mary Lou Smith, Theodore N. Tsangaris, Cheryl Williams, and Thomas Yankeelov
with her breasts), physical examination, risk assessment, screening mammography, and, in selected cases, screening MRI. A diagnostic breast evaluation differs from breast screening in that it is used to evaluate an existing problem (e.g., dominant
